PRP(27-30) is a normal soluble prion protein fragment released by human platelets

被引:70
作者
Perini, F
Vidal, R
Ghetti, B
Tagliavini, F
Frangione, B
Prelli, F
机构
[1] NYU, MED CTR, DEPT PATHOL, NEW YORK, NY 10016 USA
[2] NYU, MED CTR, DEPT NEUROL, NEW YORK, NY 10016 USA
[3] INDIANA UNIV, SCH MED, DEPT PATHOL, INDIANAPOLIS, IN 46202 USA
[4] IST NEUROL CARLO BESTA, I-20133 MILAN, ITALY
关键词
D O I
10.1006/bbrc.1996.0936
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Prion diseases are neurodegenerative disorders characterized by the accumulation of abnormal isoforms of prion protein (PrPSc) in the central nervous system. PrPSc isoforms differ from their normal homologue (PrPC), in that they possess increased beta-sheet conformation, are partially protease resistant and may be associated with amyloid deposition. Amyloid proteins are thought to derive from soluble precursors or fragments thereof, present in biological fluids, which in the disease state undergo conformational change leading to aggregation and deposition in target tissues. We report here that platelets carry PrP mRNA and release PrPC, a sialoglycoprotein bound to the cell surface by a glycosylphosphatidylinositol (GPI) anchor. Soluble PrPC and a N-terminal truncated PrPC isoform starting at position 90 are secreted by resting and agonist-stimulated platelets and are detectable after partial deglycosylation of releasates. N-terminal sequence analysis of the soluble 27-30 kDa isoform. GQGGGTHSQ(W)NKP, revealed homology to scrapie PrP27-30, the protease resistant core derived from PrPSc. These findings indicate that in addition to PrPC, platelets process a soluble PrP27-30 isoform. Whether this isoform can be converted into scrapie PrP27-30 remains to be determined. (C) 1996 Academic Press, Inc.
引用
收藏
页码:572 / 577
页数:6
相关论文
共 32 条
[11]   PRION PROTEIN TRANSGENES AND THE NEUROPATHOLOGY IN PRION-DISEASES [J].
DEARMOND, S ;
PRUSINER, SB .
BRAIN PATHOLOGY, 1995, 5 (01) :77-89
[12]   SPONTANEOUS GENERATION OF INFECTIOUS NUCLEATING AMYLOIDS IN THE TRANSMISSIBLE AND NONTRANSMISSIBLE CEREBRAL AMYLOIDOSES [J].
GAJDUSEK, DC .
MOLECULAR NEUROBIOLOGY, 1994, 8 (01) :1-13
[13]  
GARDELLA JE, 1992, LAB INVEST, V67, P303
[14]   Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: The phenotype of the stop codon 145 mutation in PRNP [J].
Ghetti, B ;
Piccardo, P ;
Spillantini, MG ;
Ichimiya, Y ;
Porro, M ;
Perini, F ;
Kitamoto, T ;
Tateishi, J ;
Seiler, C ;
Frangione, B ;
Bugiani, O ;
Giaccone, G ;
Prelli, F ;
Goedert, M ;
Dlouhy, SR ;
Tagliavini, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (02) :744-748
[15]   UNIFYING FEATURES OF SYSTEMIC AND CEREBRAL AMYLOIDOSIS [J].
GHISO, J ;
WISNIEWSKI, T ;
FRANGIONE, B .
MOLECULAR NEUROBIOLOGY, 1994, 8 (01) :49-64
[16]   PROCESSING OF A CELLULAR PRION PROTEIN - IDENTIFICATION OF N-TERMINAL AND C-TERMINAL CLEAVAGE SITES [J].
HARRIS, DA ;
HUBER, MT ;
VANDIJKEN, P ;
SHYNG, SL ;
CHAIT, BT ;
WANG, R .
BIOCHEMISTRY, 1993, 32 (04) :1009-1016
[17]   EVIDENCE FOR A SECRETORY FORM OF THE CELLULAR PRION PROTEIN [J].
HAY, B ;
PRUSINER, SB ;
LINGAPPA, VR .
BIOCHEMISTRY, 1987, 26 (25) :8110-8115
[18]  
KASESAK RJ, 1987, J VIROL, V61, P3688
[19]  
KRETZSCHMAR HA, 1986, AM J PATHOL, V122, P1
[20]   A PROTEASE-RESISTANT PROTEIN IS A STRUCTURAL COMPONENT OF THE SCRAPIE PRION [J].
MCKINLEY, MP ;
BOLTON, DC ;
PRUSINER, SB .
CELL, 1983, 35 (01) :57-62